Close

FBR Capital Starts Quest Diagnostics (DGX) at Market Perform

November 8, 2013 8:19 AM EST Send to a Friend
FBR Capital initiates coverage on Quest Diagnostics (NYSE: DGX) with a Market Perform. PT $68.00.

Analyst Tom Gallucci comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login